A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

Summary

The purpose of this study is to identify preventive treatments that can minimize the occurrence, severity, and duration of talquetamab-related taste changes (dysgeusia), during the prophylaxis (preventive) treatment phase, to better characterize the signs or symptoms of talquetamab-related taste changes and to better characterize the signs or symptoms of ramantamig-related taste changes.

Timeline

Start

2024-08-26

Primary completion

2030-05-30

Completion

2030-05-30

Drugs

Indications